Hydroxyamine hydrochloride → (NE)-N-[1-[3-[1-(5,7-difluoroquinolin-6-yl)ethyl]triazolo[4,5-b]pyrazin-5-yl]ethylidene]hydroxylamine
Reaction equation
[F:1][C:2]1[C:11]([CH:12]([N:14]2[C:18]3=[N:19][C:20]([C:23](=O)[CH3:24])=[CH:21][N:22]=[C:17]3[N:16]=[N:15]2)[CH3:13])=[C:10]([F:26])[CH:9]=[C:8]2[C:3]=1[CH:4]=[CH:5][CH:6]=[N:7]2.Cl.[NH2:28][OH:29]>>[F:1][C:2]1[C:11]([CH:12]([N:14]2[C:18]3=[N:19][C:20](/[C:23](=[N:28]/[OH:29])/[CH3:24])=[CH:21][N:22]=[C:17]3[N:16]=[N:15]2)[CH3:13])=[C:10]([F:26])[CH:9]=[C:8]2[C:3]=1[CH:4]=[CH:5][CH:6]=[N:7]2Participants
3
Procedure
The title compound (26.4 mg, 63%) was synthesized from 1-(1-(1-(5,7-difluoroquinolin-6-yl)ethyl)-1H-[1,2,3]triazolo[4,5-b]pyrazin-6-yl)ethanone (73.7) (40.0 mg, 0.11 mmol) and hydroxylamine hydrochloride (15.7 mg, 0.23 mmol) using the same procedure as described in the synthesis of example 73. 1H-NMR (400 MHz, DMSO-d6) δ ppm 12.28 (bs, 1H), 9.23 (s, 1H), 9.01 (d, 1H), 8.52 (d, 1H), 7.73 (d, 1H), 7.63 (dd, 1H), 6.80 (q, 1H), 2.36 (d, 3H), 2.05 (s, 3H). LCMS (method A): [MH]+=370, tR=5.53 min.
Workup
- customas described in the synthesis of example 73
Sources & evidence
- ORD record
- ord-637e4056cf1a43d7b0bfb4f95b0f9484
- Source dataset
- uspto-grants-2013_08
- Patent number
- US08507676B2
Reaction notes
Loading…